Passage Bio Inc. (NASDAQ: PASG)
$0.5310
-0.0050 ( -1.67% ) 70.9K
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.5310
Previous close
$0.5360
Volume
70.9K
Market cap
$32.89M
Day range
$0.5230 - $0.5700
52 week range
$0.4510 - $1.7900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 10-k | Annual reports | 89 | Mar 04, 2024 |
| 8-k | 8K-related | 46 | Mar 04, 2024 |
| 8-k | 8K-related | 14 | Feb 29, 2024 |
| 4 | Insider transactions | 1 | Feb 13, 2024 |
| 4 | Insider transactions | 1 | Feb 13, 2024 |
| 8-k | 8K-related | 42 | Jan 05, 2024 |
| 4 | Insider transactions | 1 | Jan 03, 2024 |
| 4 | Insider transactions | 1 | Jan 03, 2024 |